Small-molecule fascin inhibitors such as the NP-G2-029/NP-G2-044 series have demonstrably reduced breast cancer cell invasion and metastasis, showing syner-gistic effects with paclitaxel-based chemotherapy in murine models [134,135,136]. This evidence concerns the gene FSCN1 and breast cancer.